Table 1.
The clinicopathological features of 27 ovarian cancer patients.
| ID | Age (year) | FIGO1 stage | Pathological type | CA125 U/ml | Tumor size | Peritoneal metastasis | Relative miR-6780b-5p level |
|---|---|---|---|---|---|---|---|
| #1 | 60 | IIC | Clear cell carcinoma | 351.2 | 11.3 cm×11.3 cm×10.1 cm | No | 45.88 |
| #2 | 61 | IIIC | High-grade serous carcinoma | >1000 | 10 cm×10 cm×8 cm | Yes | 81.63 |
| #3 | 51 | IIIC | High-grade serous carcinoma | >1000 | 3.1 cm×2.2 cm | Yes | 482.18 |
| #4 | 37 | IC | Mucinous cystadenocarcinoma | 92.4 | 19 cm×14 cm×4 cm | No | 1.00 |
| #5 | 40 | IV | High-grade serous carcinoma | 600 | 8.1 cm×5.3 cm×4.6 cm, 6.3 cm×5.0 cm×4.6 cm | No | 4.87 |
| #6 | 72 | IIB | High-grade serous carcinoma | >1000 | 3 cm×3 cm | No | 55.78 |
| #7 | 43 | IIC | High-grade serous carcinoma | 1475 | 8.4 cm×10 cm×7.9 cm | Yes | 149.93 |
| #8 | 23 | IC | Borderline serous tumor | >1000 | 7.5 cm×6.7 cm×4.4 cm | No | 7.01 |
| #9 | 42 | IV | High-grade serous carcinoma | >600 | 30 cm×25 cm | Yes | 390.38 |
| #10 | 24 | IIIC | Borderline serous tumor | NA | 7.3 cm×6.1 cm,8.8 cm×6.4 cm | Yes | 275.34 |
| #11 | 45 | IIIC | High-grade serous carcinoma | 850.8 | 15 cm×15 cm | Yes | 49.54 |
| #12 | 45 | IIIB | High-grade serous carcinoma | >1000 | 6 cm×5 cm | Yes | 25.03 |
| #13 | 59 | IIIC | High-grade serous carcinoma | >1000 | 7.6 cm×6.9 cm×6.3 cm | Yes | 2.88 |
| #14 | 52 | IC | Clear cell carcinoma | 4042.5 | 16.1 cm×12.7 cm×13.6 cm | No | 6.23 |
| #15 | 52 | IC | Follicular cell tumor | >1000 | 13.0 cm×15.0 cm | No | 65.50 |
| #16 | 47 | IIIC | High-grade serous carcinoma | NA | 24.5 cm×14.5 cm×11.5 cm | Yes | 24.39 |
| #17 | 48 | IV | High-grade serous carcinoma | >1000 | 7.6 cm×4.5 cm×8.0 cm,8.9 cm×7.6 cm×9.0 cm | No | 2.71 |
| #18 | 34 | IV | Clear cell carcinoma | 431 | 21.2 cm×18.6 cm×12.7 cm | Yes | 18.04 |
| #19 | 54 | IA | Borderline mucinous tumor | 69.5 | 9.6 cm×10.1 cm×12.4 cm | No | 46.12 |
| #20 | 36 | IV | Endometrioid adenocarcinoma | >1000 | 8.2 cm×4.7 cm×5.6 cm | Yes | 14.81 |
| #21 | 47 | IIIB | High-grade serous carcinoma | 5000 | 7.1 cm×6.3 cm×5.7 cm | Yes | 97.86 |
| #22 | 43 | IIIC | High-grade serous carcinoma | >1000 | 4.8 cm×5.7 cm×3.2 cm,3.1 cm×3.7 cm×2.8 cm | Yes | 18.18 |
| #23 | 65 | IIIC | Poorly differentiated neuroendocrine carcinoma | >1000 | NA | Yes | 50.25 |
| #24 | 41 | IV | High-grade serous carcinoma | >1000 | 10.0 cm×8.6 cm×6.3 cm,7.2 cm×6.8 cm×6.5 cm | Yes | 339.63 |
| #25 | 59 | IIIC | High-grade serous carcinoma | >1000 | 3.9 cm×2.7 cm,3.5 cm×4.4 cm×2.0 cm | Yes | 179.95 |
| #26 | 11 | IIIC | Yolk sac tumor | 410.6 | 14 cm×11 cm×13 cm | Yes | 102.15 |
| #27 | 61 | IIIC | High-grade serous carcinoma | >5100 | 3 cm×3 cm×2 cm | Yes | 23.09 |
FIGO International Federation of Gynecology and Obstetrics, NA not available.